Yuchao J. Hao
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
AKT inhibitor capivasertib reverses EVI1-driven resistance to venetoclax in acute myeloid leukaemia.
AKT inhibitor capivasertib reverses EVI1-driven resistance to venetoclax in acute myeloid leukaemia.
Journal: British journal of haematology
Published: January 21, 2026
Circular nucleic acids at the host-virus interface: from immune modulation to therapeutic innovation.
Journal: Frontiers in immunology
Published: November 21, 2025
The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis.
Journal: Frontiers in immunology
Published: November 20, 2025
TREML2 enhances sensitivity of acute myeloid leukemia cells to chemotherapy by inhibiting the NF-κB/CXCL10 pathway.
Journal: Blood science (Baltimore, Md.)
Published: November 04, 2024
Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer.
Journal: Heliyon
Published: October 18, 2022
Sp1 induced gene TIMP1 is related to immune cell infiltration in glioblastoma.
Journal: Scientific reports
Published: March 11, 2022
Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.
Journal: Signal transduction and targeted therapy
Published: August 04, 2021
Author Correction: Fine dissection of the tarsal tunnel in 60 cases.
Journal: Scientific reports
Published: May 29, 2021
Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
Journal: Molecular cancer
Published: February 18, 2020
Fine dissection of the tarsal tunnel in 60 cases.
Journal: Scientific reports
Published: November 01, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026